中金:维持中国生物制药(01177)“跑赢行业”评级 目标价8.90港元 与勃林格殷格翰达成战略合作
Last Update:
6 11 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.